Published in J Am Coll Cardiol on December 01, 2009
Reversal of the Anti-platelet Effects of Ticagrelor (REVERSAL) | NCT02383771
Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK. Lancet (2014) 7.84
Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med (2015) 7.83
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA (2010) 6.29
Hospital strategies for reducing risk-standardized mortality rates in acute myocardial infarction. Ann Intern Med (2012) 2.86
Predicting clopidogrel response using DNA samples linked to an electronic health record. Clin Pharmacol Ther (2011) 2.36
Postoperative care and follow-up after coronary stenting. Dtsch Arztebl Int (2013) 2.32
Can we still rely on the ECG for detecting past myocardial injury? JACC Cardiovasc Imaging (2013) 2.02
Association between public reporting of outcomes with procedural management and mortality for patients with acute myocardial infarction. J Am Coll Cardiol (2015) 1.60
International comparison of treatment and long-term outcomes for acute myocardial infarction in the elderly: Minneapolis/St. Paul, MN, USA and Goteborg, Sweden. Eur Heart J (2013) 1.56
Expansion of invasive cardiac services in the United States. Circulation (2013) 1.54
Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting. J Am Coll Cardiol (2015) 1.52
Medical versus surgical management for vesicoureteric reflux: the case for medical management. Can Urol Assoc J (2010) 1.48
Drug-Eluting Stents versus Bare-Metal Stents in Taiwanese Patients with Acute Coronary Syndrome: An Outcome Report of a Multicenter Registry. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2014) 1.41
The aging heart and post-infarction left ventricular remodeling. J Am Coll Cardiol (2011) 1.39
Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. J Neurointerv Surg (2012) 1.28
Assessment and treatment of right ventricular failure. Nat Rev Cardiol (2013) 1.22
Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction: a 15-year single-center experience. JACC Cardiovasc Interv (2011) 1.16
Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial. Clin J Am Soc Nephrol (2013) 1.12
Temporal trends in treatment of ST-elevation myocardial infarction among men and women in Switzerland between 1997 and 2011. Eur Heart J Acute Cardiovasc Care (2012) 1.11
Reading between the (guide)lines--the KDIGO practice guideline on acute kidney injury in the individual patient. Kidney Int (2013) 1.10
Primary coronary angioplasty for ST-Elevation Myocardial Infarction in Qatar: First nationwide program. Glob Cardiol Sci Pract (2013) 1.08
Platelet-derived S100 family member myeloid-related protein-14 regulates thrombosis. J Clin Invest (2014) 1.06
Drug-eluting versus bare-metal stents in unprotected left main coronary artery stenosis a meta-analysis. JACC Cardiovasc Interv (2010) 1.05
Pharmacogenetics and cardiovascular disease--implications for personalized medicine. Pharmacol Rev (2013) 1.04
A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction. J Korean Med Sci (2013) 1.00
Brazilian recommendations of mechanical ventilation 2013. Part 2. J Bras Pneumol (2014) 0.99
Short-term outcomes of acute myocardial infarction in patients with acute kidney injury: a report from the national cardiovascular data registry. Circulation (2011) 0.98
Myocardial infarction in the elderly. Aging Dis (2010) 0.96
The CYP2C19*17 variant is not independently associated with clopidogrel response. J Thromb Haemost (2013) 0.94
Guidelines for revascularization: The evidence base matures. Glob Cardiol Sci Pract (2013) 0.94
Stroke in the TOTAL trial: a randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction. Eur Heart J (2015) 0.93
Novel antiplatelet agents in the prevention of cardiovascular complications--focus on ticagrelor. Vasc Health Risk Manag (2010) 0.92
Pulmonary Alveolar Hemorrhage after Clopidogrel Use for ST Elevation Myocardial Infarction. Korean Circ J (2013) 0.91
High residual platelet reactivity on clopidogrel: its significance and therapeutic challenges overcoming clopidogrel resistance. Cardiovasc Diagn Ther (2013) 0.91
Age and clinical outcomes in patients presenting with acute coronary syndromes. J Cardiovasc Dis Res (2013) 0.90
Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2010) 0.89
Are fourth-year medical students as prepared to manage unstable patients as they are to manage stable patients? Acad Med (2014) 0.89
Longer pre-hospital delay in first myocardial infarction among patients with diabetes: an analysis of 4266 patients in the northern Sweden MONICA Study. BMC Cardiovasc Disord (2013) 0.88
Hyperglycemia, acute insulin resistance, and renal dysfunction in the early phase of ST-elevation myocardial infarction without previously known diabetes: impact on long-term prognosis. Heart Vessels (2013) 0.88
Distinct mobilization of circulating CD271+ mesenchymal progenitors from hematopoietic progenitors during aging and after myocardial infarction. Stem Cells Transl Med (2012) 0.88
Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases. Drug Healthc Patient Saf (2010) 0.88
Impact of minimising door-to-balloon times in ST-elevation myocardial infarction to less than 30 min on outcome: an analysis over an 8-year period in a tertiary care centre. Clin Res Cardiol (2010) 0.88
Demographics and Angiographic Findings in Patients under 35 Years of Age with Acute ST Elevation Myocardial Infarction. J Tehran Heart Cent (2011) 0.87
Risk prediction models for contrast induced nephropathy: systematic review. BMJ (2015) 0.86
Variation of arterial and central venous catheter use in United States intensive care units. Anesthesiology (2014) 0.86
Fractional flow reserve application in everyday practice: adherence to clinical recommendations. Cardiovasc Diagn Ther (2013) 0.86
Elevated plasma thrombomodulin and angiopoietin-2 predict the development of acute kidney injury in patients with acute myocardial infarction. Crit Care (2014) 0.86
"Lone aspiration thrombectomy" without stenting in young patients with ST elevation myocardial infarction. Am J Cardiovasc Dis (2013) 0.86
A case of extrinsic compression of the left main coronary artery secondary to pulmonary artery dilatation. J Korean Med Sci (2013) 0.86
Early clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: insights from the National Cardiovascular Data Registry. J Am Heart Assoc (2014) 0.86
Brazilian recommendations of mechanical ventilation 2013. Part 2. Rev Bras Ter Intensiva (2014) 0.85
A prospective review of acute coronary syndromes in an urban hospital in sub-Saharan Africa. Cardiovasc J Afr (2012) 0.85
Critical appraisal of ticagrelor in the management of acute coronary syndrome. Ther Clin Risk Manag (2011) 0.85
Histopathological Comparison among Biolimus, Zotarolimus and Everolimus-Eluting Stents in Porcine Coronary Restenosis Model. Korean Circ J (2013) 0.85
Myocardial perfusion imaging with a cadmium zinc telluride-based gamma camera versus invasive fractional flow reserve. Eur J Nucl Med Mol Imaging (2013) 0.84
Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus. Wien Med Wochenschr (2010) 0.84
Significance of fragmented QRS complexes for identifying culprit lesions in patients with non-ST-elevation myocardial infarction: a single-center, retrospective analysis of 183 cases. BMC Cardiovasc Disord (2012) 0.84
A prospective, observational, multicentre study comparing tenecteplase facilitated PCI versus primary PCI in Indian patients with STEMI (STEPP-AMI). Open Heart (2014) 0.84
Effects of Intra-Arterial and Intravenous Iso-Osmolar Contrast Medium (Iodixanol) on the Risk of Contrast-Induced Acute Kidney Injury: A Meta-Analysis. Cardiorenal Med (2011) 0.84
Health-related quality-of-life after percutaneous coronary intervention in patients with UA/NSTEMI and STEMI: the Korean multicenter registry. J Korean Med Sci (2013) 0.83
Comparison of clinical outcomes of hydrophilic and lipophilic statins in patients with acute myocardial infarction. Korean J Intern Med (2011) 0.83
Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients. Heart Vessels (2015) 0.83
Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agents. Circulation (2011) 0.83
High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study. JACC Cardiovasc Imaging (2012) 0.83
Emerging antiplatelet agents, differential pharmacology, and clinical utility. J Blood Med (2010) 0.83
Pharmacogenomics of anti-platelet therapy: how much evidence is enough for clinical implementation? J Hum Genet (2013) 0.83
Reperfusion therapy and mortality in octogenarian STEMI patients: results from the Belgian STEMI registry. Clin Res Cardiol (2013) 0.83
Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy. World J Crit Care Med (2015) 0.82
Association of admission serum calcium levels and in-hospital mortality in patients with acute ST-elevated myocardial infarction: an eight-year, single-center study in China. PLoS One (2014) 0.82
Percutaneous treatment of iatrogenic left main ostial stenosis: after a Bentall operation. Tex Heart Inst J (2012) 0.82
Early coronary revascularization improves 24h survival and neurological function after ischemic cardiac arrest. A randomized animal study. Resuscitation (2013) 0.82
Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis. Kidney Int (2015) 0.82
Outcomes following percutaneous coronary intervention and coronary artery bypass grafting surgery in Chinese, South Asian and White patients with acute myocardial infarction: administrative data analysis. BMC Cardiovasc Disord (2013) 0.81
Effect of age on clinical presentation and outcome of patients hospitalized with acute coronary syndrome: a 20-year registry in a middle eastern country. Open Cardiovasc Med J (2012) 0.81
Implementation of Cell Samples as Controls in National Proficiency Testing for Clopidogrel Therapy-Related CYP2C19 Genotyping in China: A Novel Approach. PLoS One (2015) 0.81
Comparison of the efficacy of drug-eluting stents versus bare-metal stents for the treatment of left main coronary artery disease. Chin Med J (Engl) (2015) 0.80
Genetic and Nongenetic Factors Affecting Clopidogrel Response in the Egyptian Population. Clin Transl Sci (2016) 0.80
Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty. Vasc Health Risk Manag (2012) 0.80
Pharmaco-mechanic antithrombotic strategies to reperfusion of the infarct-related artery in patients with ST-elevation acute myocardial infarctions. J Cardiovasc Transl Res (2013) 0.80
Timely reperfusion for ST-segment elevation myocardial infarction: Effect of direct transfer to primary angioplasty on time delays and clinical outcomes. World J Cardiol (2014) 0.80
Nifekalant in the treatment of life-threatening ventricular tachyarrhythmias. World J Cardiol (2011) 0.80
Diagnostic evaluation of the MRP-8/14 for the emergency assessment of chest pain. J Thromb Thrombolysis (2012) 0.80
Dipyridamole with low-dose aspirin augments the infarct size-limiting effects of simvastatin. Cardiovasc Drugs Ther (2010) 0.80
Trends in hospital discharges, management and in-hospital mortality from acute myocardial infarction in Switzerland between 1998 and 2008. BMC Public Health (2013) 0.80
Leucocytoclastic vasculitis as a late complication of clopidogrel therapy. BMJ Case Rep (2013) 0.80
Tirofiban-induced diffuse alveolar hemorrhage: after primary angioplasty. Tex Heart Inst J (2012) 0.80
Primary angioplasty in Europe: From trials to practice. Glob Cardiol Sci Pract (2013) 0.80
Prognosis of patients with atrial fibrillation undergoing percutaneous coronary intervention receiving drug eluting stents. Clin Res Cardiol (2013) 0.80
Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting. Clin Res Cardiol (2012) 0.79
Pentraxin 3 Is Highly Specific for Predicting Anatomical Complexity of Coronary Artery Stenosis as Determined by the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery Score. Korean Circ J (2014) 0.79
Evolution of Myocardial Infarction and its Biomarkers: A Historical Perspective. Heart Views (2017) 0.79
Combined biomarker analysis for risk of acute kidney injury in patients with ST-segment elevation myocardial infarction. PLoS One (2015) 0.79
The safety of beta-blocker use in chronic obstructive pulmonary disease patients with respiratory failure in the intensive care unit. Multidiscip Respir Med (2014) 0.79
Cardiovascular Toxicity of Molecular Targeted Therapy in Cancer Patients: A Double-Edged Sword. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2013) 0.79
Comparison of percutaneous coronary intervention safety before and during the establishment of a transradial program at a teaching hospital. Am J Cardiol (2012) 0.79
An overview of PCI in the very elderly. J Geriatr Cardiol (2015) 0.79
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation (2004) 23.07
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation (2004) 20.67
Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation (2010) 19.30
Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2007) 17.85
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18
Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA (2004) 14.05
Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA (2009) 13.69
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med (2003) 13.29
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation (2004) 13.07
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA (2008) 12.36
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
Universal definition of myocardial infarction. Circulation (2007) 11.69
Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med (2009) 11.51
Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42
Telemonitoring in patients with heart failure. N Engl J Med (2010) 10.82
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA (2003) 10.55
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38
Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med (2008) 9.25
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Delayed time to defibrillation after in-hospital cardiac arrest. N Engl J Med (2008) 8.36
Application of new cholesterol guidelines to a population-based sample. N Engl J Med (2014) 8.22
Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med (2006) 8.18
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med (2013) 8.08
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94